Apigenin in Combination with Akt Inhibition Significantly Enhances Thyrotropin-Stimulated Radioiodide Accumulation in Thyroid Cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Thyroid

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/thy.2013.0614PMID 24400871PMCID PMC4026312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

  2014cited by this paper
• N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties

  2014cited by this paper
• Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

  2013cited by this paper
• Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.

  2013cited by this paper
• SLIT2 inhibits cell migration in colorectal cancer through the AKT–GSK3β signaling pathway

  2013cited by this paper
• Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma

  2013influential reference
• Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E

  2013cited by this paper
• Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells.

  2013cited by this paper
• Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells.

  2013cited by this paper
• Curcumin Suppresses Doxorubicin-Induced Epithelial-Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells

  2013influential reference
• BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer

  2012cited by this paper
• Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.

  2012cited by this paper
• Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.

  2011cited by this paper
• Phosphorylation and Activation of the Plasma Membrane Na+/H+ Exchanger (NHE1) during Osmotic Cell Shrinkage

  2011cited by this paper
• First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.

  2011cited by this paper
• Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

  2011cited by this paper
• Single photon emission computed tomography imaging for temporal dynamics of thyroidal and salivary radionuclide accumulation in 17-allyamino-17-demothoxygeldanamycin-treated thyroid cancer mouse model.

  2010cited by this paper
• Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein–27

  2010influential reference
• The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.

  2009influential reference
• Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells

  2009influential reference
• Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake

  2008cited by this paper
• Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study.

  2008cited by this paper
• Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.

  2008cited by this paper
• MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.

  2007influential reference
• Identification of in Vivo Phosphorylation Sites and Their Functional Significance in the Sodium Iodide Symporter*

  2007cited by this paper
• Inhibition of PKB/Akt activity involved in apigenin-induced apoptosis in human gastric carcinoma cells

  2007cited by this paper
• Suppression of BRAF/MEK/MAP Kinase Pathway Restores Expression of Iodide-Metabolizing Genes in Thyroid Cells Expressing the V600E BRAF Mutant

  2007cited by this paper
• Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

  2007influential reference
• Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells.

  2006cited by this paper
• Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

  2006cited by this paper
• Inhibition of TPA‐induced cyclooxygenase‐2 (COX‐2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes

  2005cited by this paper
• Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.

  2005cited by this paper
• Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways

  2005cited by this paper
• Simple solution to a common statistical problem: interpreting multiple tests.

  2004influential reference
• Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells*

  2004cited by this paper
• Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway*

  2004cited by this paper
• The Functional Interaction between the Paired Domain Transcription Factor Pax8 and Smad3 Is Involved in Transforming Growth Factor-β Repression of the Sodium/Iodide Symporter Gene*

  2004cited by this paper
• TGF-beta control of rat thyroid follicular cells differentiation.

  2003cited by this paper
• Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.

  2003cited by this paper
• TGF-β control of rat thyroid follicular cells differentiation

  2003cited by this paper
• Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis

  2003cited by this paper
• Mice with a Mutation in the Thyroid Hormone Receptor β Gene Spontaneously Develop Thyroid Carcinoma: A Mouse Model of Thyroid Carcinogenesis

  2002cited by this paper
• The Elicitor Cryptogein Blocks Glucose Transport in Tobacco Cells1

  2002cited by this paper
• Post-transcriptional Regulation of the Sodium/Iodide Symporter by Thyrotropin*

  2001cited by this paper
• Regulation of FRTL-5 Thyroid Cell Growth by Phosphatidylinositol (OH) 3 Kinase-Dependent Akt-Mediated Signaling

  2001cited by this paper
• Thyroid-stimulating Hormone and Cyclic AMP Activate p38 Mitogen-activated Protein Kinase Cascade

  2000cited by this paper
• Thyroid-stimulating Hormone and Cyclic AMP Activate p38 Mitogen-activated Protein Kinase Cascade INVOLVEMENT OF PROTEIN KINASE A, Rac1, AND REACTIVE OXYGEN SPECIES*

  2000cited by this paper
• Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone.

  2000cited by this paper
• Regulation of Protein Kinase C Isoforms in FRTL-5 Thyroid Cells by TSH and Phorbol Ester

  1996cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979influential reference

• Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment

  2025cites this paper
• The Toxicological Role of Myricetin in the Progression of Human Anaplastic Thyroid Cancer SW1736 Cell Line.

  2024cites this paper
• Plant constituents and thyroid: a revision of the main phytochemicals that interfere with thyroid function.

  2021cites this paper
• Apigenin as an anticancer agent.

  2020cites this paper
• Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma

  2020cites this paper
• Redifferentiation of radioiodine-refractory thyroid cancers.

  2020cites this paper
• Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies

  2020cites this paper
• Plant natural products with anti-thyroid cancer activity.

  2020cites this paper
• Rationalizing the therapeutic potential of apigenin against cancer.

  2020cites this paper
• Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers

  2019cites this paper
• Flavonoids, Thyroid Iodide Uptake and Thyroid Cancer—A Review

  2017cites this paper
• N-Acetyl-l-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation

  2017cites this paper
• N-Acetyl-l-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation

  2017cites this paper
• Rutin Scavenges Reactive Oxygen Species, Inactivates 5′-Adenosine Monophosphate-Activated Protein Kinase, and Increases Sodium–Iodide Symporter Expression in Thyroid PCCL3 Cells

  2017cites this paper
• Plant Flavone Apigenin: an Emerging Anticancer Agent

  2017cites this paper
• Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

  2015cites this paper
• Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells.

  2015cites this paper
• Modulation of Sodium Iodide Symporter-mediated Thyroidal Radioiodide Uptake by Small Molecule Inhibitors, Natural Plant-based Products and microRNAs

  2015influential citation
• Modulation of Sodium Iodide Symporter in Thyroid Cancer

  2014cites this paper